Literature DB >> 26184415

Misregulation effect of a novel allelic variant in the Z promoter region found in cis with the CYP21A2 p.P482S mutation: implications for 21-hydroxylase deficiency.

Cecilia S Fernández1, Carlos D Bruque, Melisa Taboas, Noemí D Buzzalino, Lucia D Espeche, Titania Pasqualini, Eduardo H Charreau, Liliana G Alba, Pablo D Ghiringhelli, Liliana Dain.   

Abstract

The aim of the current study was to search for the presence of genetic variants in the CYP21A2 Z promoter regulatory region in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Screening of the 10 most frequent pseudogene-derived mutations was followed by direct sequencing of the entire coding sequence, the proximal promoter, and a distal regulatory region in DNA samples from patients with at least one non-determined allele. We report three non-classical patients that presented a novel genetic variant-g.15626A>G-within the Z promoter regulatory region. In all the patients, the novel variant was found in cis with the mild, less frequent, p.P482S mutation located in the exon 10 of the CYP21A2 gene. The putative pathogenic implication of the novel variant was assessed by in silico analyses and in vitro assays. Topological analyses showed differences in the curvature and bendability of the DNA region bearing the novel variant. By performing functional studies, a significantly decreased activity of a reporter gene placed downstream from the regulatory region was found by the G transition. Our results may suggest that the activity of an allele bearing the p.P482S mutation may be influenced by the misregulated CYP21A2 transcriptional activity exerted by the Z promoter A>G variation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26184415     DOI: 10.1007/s12020-015-0680-0

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  27 in total

1.  A case of patient affected by hirsutism carrying the P482S CYP21 gene mutation associated with loss of heterozygosity (LOH).

Authors:  Paola Concolino; Cinzia Carrozza; Angelo Minucci; Concetta Santonocito; Franco Ameglio; Cecilia Zuppi; Ettore Capoluongo
Journal:  Clin Chim Acta       Date:  2006-02-28       Impact factor: 3.786

2.  Functional characterization of three CYP21A2 sequence variants (p.A265V, p.W302S, p.D322G) employing a yeast co-expression system.

Authors:  Caroline Bleicken; Lourdes Loidi; Vivek Dhir; Silvia Parajes; Celsa Quinteiro; Fernando Dominguez; Joachim Grötzinger; Wolfgang G Sippell; Felix G Riepe; Wiebke Arlt; Nils Krone
Journal:  Hum Mutat       Date:  2009-02       Impact factor: 4.878

3.  Functional consequences of a novel point mutation in the CYP21A2 gene identified in a Chinese Han patient with nonclassic 21-hydroxylase deficiency.

Authors:  Xiaojing Chu; Hu Ding; Guanglin Cui; Yujun Xu; Dao Wen Wang; Yebing He
Journal:  Clin Endocrinol (Oxf)       Date:  2013-09-05       Impact factor: 3.478

4.  Adrenal 21-hydroxylase gene mutations in Slovenian hyperandrogenic women: evaluation of corticotrophin stimulation and HLA polymorphisms in screening for carrier status.

Authors:  V Dolzan; J Prezelj; B Vidan-Jeras; K Breskvar
Journal:  Eur J Endocrinol       Date:  1999-08       Impact factor: 6.664

5.  Hyperandrogenism in carriers of CYP21 mutations: the role of genotype.

Authors:  Osnat Admoni; Shosh Israel; Idit Lavi; Michal Gur; Yardena Tenenbaum-Rakover
Journal:  Clin Endocrinol (Oxf)       Date:  2006-06       Impact factor: 3.478

6.  A promoter within intron 35 of the human C4A gene initiates abundant adrenal-specific transcription of a 1 kb RNA: location of a cryptic CYP21 promoter element?

Authors:  M K Tee; G O Babalola; P Aza-Blanc; M Speek; S E Gitelman; W L Miller
Journal:  Hum Mol Genet       Date:  1995-11       Impact factor: 6.150

7.  Difference in transcriptional activity of two homologous CYP21A genes.

Authors:  S F Chang; B C Chung
Journal:  Mol Endocrinol       Date:  1995-10

Review 8.  Trinucleotide models for DNA bending propensity: comparison of models based on DNaseI digestion and nucleosome packaging data.

Authors:  I Brukner; R Sánchez; D Suck; S Pongor
Journal:  J Biomol Struct Dyn       Date:  1995-10

9.  Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency.

Authors:  Rogério S Araújo; Berenice B Mendonca; Angela S Barbosa; Chin J Lin; José A M Marcondes; Ana Elisa C Billerbeck; Tânia A S S Bachega
Journal:  J Clin Endocrinol Metab       Date:  2007-07-31       Impact factor: 5.958

10.  Functional analysis of two recurrent amino acid substitutions in the CYP21 gene from Italian patients with congenital adrenal hyperplasia.

Authors:  M Barbaro; S Lajic; L Baldazzi; A Balsamo; P Pirazzoli; A Cicognani; A Wedell; E Cacciari
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

View more
  1 in total

1.  Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project.

Authors:  Ozge Ceyhan-Birsoy; Jaclyn B Murry; Kalotina Machini; Matthew S Lebo; Timothy W Yu; Shawn Fayer; Casie A Genetti; Talia S Schwartz; Pankaj B Agrawal; Richard B Parad; Ingrid A Holm; Amy L McGuire; Robert C Green; Heidi L Rehm; Alan H Beggs
Journal:  Am J Hum Genet       Date:  2019-01-03       Impact factor: 11.025

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.